News
RGCC Unveils Revolutionary Cancer Detection Test, Onco-D-clare
RGCC announces the launch of Onco-D-clare, a groundbreaking cancer detection test that marks a significant milestone in early cancer screening. Utilizing the cutting-edge technology of molecular biology coupled with artificial neural networks, this innovative test empowers individuals to detect cancer before symptoms manifest. Onco-D-clare operates by isolating peripheral blood mononuclear cells from blood samples, followed […]